leisure time -WSS

leisure time

author：hotspot 2025-09-28 23:11:46 - browse：7641

Emergent BioSolutions, the manufacturing company that fell into hot water in 2021 due to a contamination issue involving millions of doses of Covid vaccines, is pivoting its business and cutting hundreds of jobs, including a C-suite role.

The company announced Tuesday that it will cut 400 jobs and eliminate the role of chief operating officer as part of a shift away from its contract manufacturing services business. The current chief operating officer, Adam Havey, will leave the company on Sept. 30.

Instead, Emergent will focus on producing Narcan nasal spray and other products. The overdose reversal medicine became available as an over-the-counter medicine earlier this year.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Duchenne breakthrough therapy leaves behind pioneering families
Next article： Q&A: Jennifer Adair on making gene therapy available globally

WSS

BIO: Crackdown on China pharma industry would threaten U.S. drug supply

3 medical device trends to watch in 2024

3 medical device trends to watch in 2024

After traumatic brain injury, life support decisions can use more time

AdventHealth escalates lawsuit against insurance vendor Multiplan

Videos point to link between seizures and unexplained toddler deaths

entertainment

leisure time

knowledge

FDA approval of Sarepta Duchenne genetic therapy gives me hope

At JPM, Bristol Myers Squibb CEO tries to soothe investor nerves

Virginia high school admissions case could be legal follow

AdventHealth escalates lawsuit against insurance vendor Multiplan

Continuity nursing helped my family in our darkest PICU moments

Why psychiatrists like me stop taking insurance

Affirmative action in medical school literally saved lives

Feng Zhang CRISPR delivery startup lays off quarter of staff

Trump demands the U.S. pay no more for drugs than other countries … again

The FDA must approve intranasal treatments for anaphylaxis

hotspot

Why psychiatrists like me stop taking insurance

Insitro, AI biotech unicorn, brings cash, new research to JPM 2024

U.K. sequencing study surfaces new findings about tumor DNA

3 medical device trends to watch in 2024

Medical bills so high, Medicare adding extra digits to claim forms

Getting Alzheimer's drug Leqembi to patients can be a challenge

entertainment

focus

hotspot

hotspot